PDT Partners, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$149,000
-12.9%
55,3990.0%0.01%
+9.1%
Q1 2016$171,000
-19.7%
55,3990.0%0.01%
-62.1%
Q4 2015$213,000
+29.1%
55,399
+303.4%
0.03%
+625.0%
Q1 2014$165,000
-45.4%
13,732
-51.0%
0.00%
-50.0%
Q3 2013$302,00028,0000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Perceptive Advisors 5,408,728$17,037,0000.97%
WealthTrust Axiom LLC 140,000$441,0000.16%
Palo Alto Investors LP 1,032,715$3,253,0000.15%
SHEPHERD KAPLAN KROCHUK, LLC 49,761$157,0000.08%
Joel Isaacson & Co., LLC 80,660$254,0000.05%
Malaga Cove Capital, LLC 10,250$31,0000.02%
Cornerstone Capital, Inc. 30,000$95,0000.02%
Granahan Investment Management 31,298$99,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 244,150$769,0000.01%
Advisor Group, Inc. 117,657$371,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders